WHC is still in active development. Read this to understand our approach.
depiction of GGCSSNBKKAUURC-UHFFFAOYSA-N.svg
tripsit

sufentanil

Verificar en tripsit

psychonaut

Sufentanil

Verificar en psychonaut

isomerdesign

Sufentanil

Verificar en isomerdesign

pubchem

Sufentanil

Verificar en pubchem

druglab

Sufentanil

Verificar en druglab

drugmap

Sufentanil

Verificar en drugmap

wiki

Sufentanil

Verificar en wiki

Data

InChI: InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3

Sinónimos: SUFENTANIL [MART.],SUFENTANIL [INN],L000580,R 30,730,BDBM94503, N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide,SUFENTANIL [MI], Sufentil (TN), Sufentanilum [INN-Latin],DB00708,NCGC00247355-01,N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide,N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide,cid_65494,UNII-AFE2YW0IIZ,N-[4-(Methoxymethyl)-1-{2-(2-thienyl)ethyl}-4-piperidinyl]-N-phenylpropanamide,C08022,ZINC538386,Sufentanyl,N-(4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl)-N-phenylpropanamide #,N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,Chronogesic,SCHEMBL26728, R-30730,SUFENTANIL [VANDF],N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]propionalnalide,R-30730,Sufentanil Base,citric acid;N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenyl-propionamide, Sufenta (TN), N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide, N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide,Dsuvia (brand name),Sufentanil [USAN:INN:BAN],Oprea1_246787,PDSP1_001741,SUFENTANIL,IDS-NS-001,2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidinyl]-N-phenylpropanamide,Zalviso,ARX 04,56030-54-7,PDSP2_001724,CHEBI:9316, Sulfentanil, Sufentanil (USAN/INN),Q417915,Sufentanilum [INN-Latin],Sufentanilum,Epitope ID:153513,Oprea1_120838, Sulfentanyl, Sufentanilum,N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,D05938,HSDB 6760,AFE2YW0IIZ,N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide,Sufenta (brand name),DTXSID6023604,Propanamide, N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-,SUFENTANIL [USAN],HY-13754,N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide,SUFENTANIL [EP MONOGRAPH], N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenyl-propanamide;2-oxidanylpropane-1,2,3-tricarboxylic acid,CHEMBL658,Sufentanil (USAN/INN), N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide,R 30730,Sufentanil, Sufentanil [USAN:BAN:INN], R 30730,SUFENTANIL [WHO-DD],ARX04,N-[4-(Methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidyl]-N-phenyl-propanamide,SUFENTANIL [HSDB],N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide,Propanamide, N-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenyl-, Sufentanyl,GTPL3534

Estimated data

Solubilidad: -4.206 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 81.8% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.